mpox

Pharma

Bavarian Nordic confirms buyout talks

Bavarian Nordic, maker of the chikungunya vaccine Vimkunya, is in talks with private equity firms Nordic Capital and Permira about a potential takeover.

Angus Liu Jul 24, 2025 11:13am

Bavarian Nordic CEO highlights travel health as key sales driver

Mar 6, 2025 9:04am

JPM25: Recovering Emergent inks deal for opioid overdose spray

Jan 15, 2025 7:41pm

Bavarian Nordic inks mpox vaccine pact with major vaccine player

Dec 16, 2024 9:06am

Siga's Tpoxx misses the mark in another mpox study

Dec 12, 2024 8:55am

NIH study shows mpox shot elicits immune response in teens

Oct 17, 2024 11:17am